中国感染控制杂志
中國感染控製雜誌
중국감염공제잡지
CHINESE JOURNAL OF INFECTION CONTROL
2015年
1期
38-41
,共4页
唐国传%林海%黄宁芳%唐尚伟%余祖辉%颜钟生%劳显丽%邓云广
唐國傳%林海%黃寧芳%唐尚偉%餘祖輝%顏鐘生%勞顯麗%鄧雲廣
당국전%림해%황저방%당상위%여조휘%안종생%로현려%산운엄
头孢克洛缓释片%递减方案%再发性尿路感染%治疗研究
頭孢剋洛緩釋片%遞減方案%再髮性尿路感染%治療研究
두포극락완석편%체감방안%재발성뇨로감염%치료연구
cefaclor sustained release tablet%diminishing scheme%recurrent urinary tract infection%therapy re-search
目的:观察头孢克洛缓释片递减方案治疗再发性尿路感染(RUTI)的效果及不良反应。方法将某院60例 RUTI 患者按来诊顺序分为治疗组和对照组,各30例,治疗组用头孢克洛缓释片递减方案治疗,对照组用左氧氟沙星片递减方案治疗,观察两组治疗方案临床疗效和不良反应情况。结果治疗组临床治愈24例(80.00%),对照组临床治愈16例(53.33%),治疗组临床治愈率高于对照组,与对照组比较差异有统计学意义(χ2=4.80,P =0.028)。治疗组发生 RUTI 2例(6.67%),对照组发生 RUTI 8例(26.67%),治疗组再发率低于对照组,差异有统计学意义(χ2=4.32,P =0.038)。治疗组不良反应发生率为16.67%,低于对照组的50.00%,差异有统计学意义(χ2=7.50,P =0.006)。结论头孢克洛缓释片递减方案治疗 RUTI 疗效好、再发率低、不良反应少,可用于防止 RUTI 再发的治疗。
目的:觀察頭孢剋洛緩釋片遞減方案治療再髮性尿路感染(RUTI)的效果及不良反應。方法將某院60例 RUTI 患者按來診順序分為治療組和對照組,各30例,治療組用頭孢剋洛緩釋片遞減方案治療,對照組用左氧氟沙星片遞減方案治療,觀察兩組治療方案臨床療效和不良反應情況。結果治療組臨床治愈24例(80.00%),對照組臨床治愈16例(53.33%),治療組臨床治愈率高于對照組,與對照組比較差異有統計學意義(χ2=4.80,P =0.028)。治療組髮生 RUTI 2例(6.67%),對照組髮生 RUTI 8例(26.67%),治療組再髮率低于對照組,差異有統計學意義(χ2=4.32,P =0.038)。治療組不良反應髮生率為16.67%,低于對照組的50.00%,差異有統計學意義(χ2=7.50,P =0.006)。結論頭孢剋洛緩釋片遞減方案治療 RUTI 療效好、再髮率低、不良反應少,可用于防止 RUTI 再髮的治療。
목적:관찰두포극락완석편체감방안치료재발성뇨로감염(RUTI)적효과급불량반응。방법장모원60례 RUTI 환자안래진순서분위치료조화대조조,각30례,치료조용두포극락완석편체감방안치료,대조조용좌양불사성편체감방안치료,관찰량조치료방안림상료효화불량반응정황。결과치료조림상치유24례(80.00%),대조조림상치유16례(53.33%),치료조림상치유솔고우대조조,여대조조비교차이유통계학의의(χ2=4.80,P =0.028)。치료조발생 RUTI 2례(6.67%),대조조발생 RUTI 8례(26.67%),치료조재발솔저우대조조,차이유통계학의의(χ2=4.32,P =0.038)。치료조불량반응발생솔위16.67%,저우대조조적50.00%,차이유통계학의의(χ2=7.50,P =0.006)。결론두포극락완석편체감방안치료 RUTI 료효호、재발솔저、불량반응소,가용우방지 RUTI 재발적치료。
Objective To explore the efficacy and adverse reactions of diminishing scheme of cefaclor sustained re-lease tablets in the treatment of recurrent urinary tract infection(RUTI).Methods 60 RUTI patients in a hospital were divided into treatment group(n=30)and control group (n=30),patients in treatment group were treated with diminishing scheme of cefaclor sustained release tablets,patients in control group were treated with diminishing scheme of levofloxacin tablets,clinical therapeutic efficacy and adverse reactions of two groups were observed. Results The curative rate in treatment group was higher than control group ([80.00%,n =24]vs [53.33%,n =16])(χ2 =4.80,P =0.028).The incidence of RUTI in treatment group was lower than control group ([6.67%,n=2]vs [26.67%,n=8])(χ2 =4.32,P =0.038).Incidence of adverse reactions in treatment group was lower than control group (16.67% vs 50.00%)(χ2 =7.50,P =0.006).Conclusion The diminishing scheme of cefaclor sus-tained release tablets in the treatment of RUTI has good curative efficacy,low recurrence rate,fewer adverse reac-tions,and can be used for the treatment of recurrence of RUTI.